Disseminated mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages 415-421

  Biggs, H M ^a   ChudgarS M , ^a   Pfeiffer, C D ^a   Rice, K R ^a   Zaas, A K ^a   Wolfe, C R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Mycobacterium immunogenum; Rapidly growing mycobacteria; Renal transplant

Indexed keywords

ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CEFTAZIDIME; HYDROCORTISONE; LINEZOLID; MOXIFLOXACIN; NORADRENALIN; POLITEF; PREDNISONE; TACROLIMUS; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADRENAL INSUFFICIENCY; ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; AORTA STENOSIS; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; CYTOMEGALOVIRUS; DISEASE SEVERITY; ERYTHEMA; GENE SEQUENCE; GRAFT RECIPIENT; HEMODIALYSIS; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG EDEMA; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM IMMUNOGENUM; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPTIC SHOCK; SKIN BIOPSY; SKIN DEFECT; SUPPURATION; TREATMENT OUTCOME; VIRUS REACTIVATION;

ANTI-BACTERIAL AGENTS; FATAL OUTCOME; HUMANS; KIDNEY TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SHOCK, SEPTIC; SKIN DISEASES, BACTERIAL;

EID: 84865186362     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00730.x     Document Type: Article

References (24)

1. Wilson RW, Steingrube VA, Bottger EC, et al. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol 2001; 51 (Pt 5): 1751-1764.
2. Lowry PW, Beck-Sague CM, Bland LA, et al. Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis 1990; 161: 85-90.
3. Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc 2010; 42 (8): 3058-3060.
4. Tillie-Leblond I, Grenouillet F, Reboux G, et al. Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J 2011; 37 (3): 640-647.
5. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15 (4): 716-746.
6. Steele LC, Wallace RJ Jr. Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae. J Clin Microbiol 1987; 25 (2): 456-457.
7. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol 1982; 16 (6): 1003-1006.
8. CLSI. Susceptibility Testing of Mycobacteria N, and Other Aerobic Actinomycetes; Approved Standard-Second Edition. CLSI document M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2011.
9. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006; 42 (12): 1756-1763.
10. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med 2007; 175 (4): 367-416.
11. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5 (4): 657-679.
12. Loots MA, de Jong MD, van Soolingen D, Wetsteyn JC, Faber WR. Chronic leg ulcer caused by Mycobacterium immunogenum. J Travel Med 2005; 12 (6): 347-349.
13. Sampaio JL, Junior DN, de Freitas D, et al. An outbreak of keratitis caused by Mycobacterium immunogenum. J Clin Microbiol 2006; 44 (9): 3201-3207.
14. Del-Castillo M, Palmero D, Lopez B, et al. Mesotherapy-associated outbreak caused by Mycobacterium immunogenum. Emerg Infect Dis 2009; 15 (2): 357-359.
15. Shedd AD 4th, Edhegard KD 2nd, Lugo-Somolinos A. Mycobacterium immunogenum skin infections: two different presentations. Int J Dermatol 2010; 49 (8): 941-944.
16. Mitchell CB, Isenstein A, Burkhart CN, Groben P, Morrell DS. Infection with Mycobacterium immunogenum following a tattoo. J Am Acad Dermatol 2011; 64 (5): e70-e71.
17. Drage LA, Ecker PM, Orenstein R, Phillips PK, Edson RS. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol 2010; 62 (3): 501-506.
18. Bechara C, Macheras E, Heym B, Pages A, Auffret N. Mycobacterium abscessus skin infection after tattooing: first case report and review of the literature. Dermatology 2010; 221 (1): 1-4.
19. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166 (2): 405-412.
20. Brown-Elliott BA, Wallace RJ Jr. Mycobacterium: clinical and laboratory characteristics of rapidly growing mycobacteria. In: Murray PR, Barron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of Clinical Microbiology. Washington D.C.: ASM Press, 2007: 589-600.
21. Yakrus MA, Hernandez SM, Floyd MM, Sikes D, Butler WR, Metchock B. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J Clin Microbiol 2001; 39: 4103-4110.
22. Fernandez-Roblas R, Martin-de-Hijas NZ, Fernandez-Martinez AI, Garcia-Almeida D, Gadea I, Esteban J. In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother 2008; 52 (11): 4184-4186.
23. Garrison AP, Morris MI, Doblecki Lewis S, et al. Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis 2009; 11 (6): 541-548.
24. Peres E, Khaled Y, Krijanovski OI, et al. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline. Transpl Infect Dis 2009; 11 (1): 57-63.